NCT03841084View on ClinicalTrials.gov

Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

June 3, 2023

Study Completion Date

July 1, 2023

Conditions

Cardiac FailureCritical Illness

Interventions

DRUG

Oxygen

"Conservative oxygen management strategy- reduces oxygen on the inoblender in the ECMO circuit.~Liberal oxygen management strategy - does not reduce the oxygen on the inoblender via the ECMO circuit"

Trial Locations (1)

3004

Alfred Health, Melbourne

All Listed Sponsors

lead

Australian and New Zealand Intensive Care Research Centre

OTHER

NCT03841084 - Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial | Biotech Hunter | Biotech Hunter